Ideaya Biosciences Inc Asset Turnover Ratio (IDYA), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ideaya Biosciences Inc   (NASDAQ: IDYA)
 

Ideaya Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Ideaya Biosciences Inc 's asset turnover ratio sequentially decreased to 0.2 in the second quarter (Jun 30 2026), but remained above the company's average. For every Dollar on the Balance Sheet, Ideaya Biosciences Inc realized $0.2 in annual sales.

Within sector 135 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IDYA Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 26.95 % -4.46 % 0.07 % -4.73 % 4.85 %
Y / Y Revenue Change - - 55.37 % - -
Asset Turnover Ratio (TTM) 0.2 0.21 0.2 0.2 -
IDYA's Total Ranking # # # # #
Seq. Asset Change 25.62 % -7.12 % -4.68 % 14.15 % -5.46 %
Seq. Revenue Change 35.02 % -39.68 % -94.77 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 136
Healthcare Sector # 424
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.2 0.11 0.05
(Jun 30 2026)   (Dec 31 2023)




IDYA Company Profile • Back to IDYA Efficiency Comparisons • Compare IDYA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Alkermes Plc   0.50 $ 1,667.652  Millions$ 3,366.927  Millions
Rapid Micro Biosystems Inc   0.49 $ 34.545  Millions$ 70.018  Millions
Johnson and Johnson  0.49 $ 97,929.000  Millions$ 198,495.250  Millions
Tenon Medical Inc   0.48 $ 5.312  Millions$ 10.971  Millions
Vertex Pharmaceuticals Inc  0.48 $ 12,587.200  Millions$ 26,103.250  Millions
Edwards Lifesciences Corporation  0.48 $ 6,512.500  Millions$ 13,539.425  Millions
Bio techne Corp  0.48 $ 1,213.869  Millions$ 2,555.336  Millions
Scientific Industries Inc   0.47 $ 5.728  Millions$ 12.094  Millions
Pacific Health Care Organization Inc  0.47 $ 6.442  Millions$ 13.658  Millions
Quidelortho Corp  0.47 $ 2,674.200  Millions$ 5,697.100  Millions
Organon and Co   0.47 $ 6,139.000  Millions$ 13,148.250  Millions
Sbc Medical Group Holdings Incorporated  0.46 $ 173.713  Millions$ 374.122  Millions
Integra Lifesciences Holdings Corp  0.46 $ 1,647.666  Millions$ 3,597.417  Millions
Bionano Genomics Inc   0.46 $ 30.176  Millions$ 66.260  Millions
Cumberland Pharmaceuticals Inc   0.45 $ 31.269  Millions$ 69.149  Millions
Syndax Pharmaceuticals Inc   0.45 $ 252.004  Millions$ 564.455  Millions
Arvinas Inc   0.44 $ 316.700  Millions$ 721.200  Millions
Picard Medical Inc   0.42 $ 5.983  Millions$ 14.114  Millions
Dyadic International Inc   0.42 $ 3.802  Millions$ 8.991  Millions
Surgery Partners Inc   0.42 $ 3,366.300  Millions$ 8,039.525  Millions
Regenxbio Inc   0.41 $ 174.482  Millions$ 426.687  Millions
Quanterix Corporation  0.39 $ 152.716  Millions$ 387.301  Millions
Bausch and Lomb Corp  0.38 $ 5,324.000  Millions$ 13,873.250  Millions
Biomarin Pharmaceutical Inc  0.38 $ 3,406.614  Millions$ 8,880.837  Millions
Veracyte Inc   0.38 $ 544.735  Millions$ 1,424.143  Millions
Beta Bionics Inc   0.38 $ 119.513  Millions$ 313.898  Millions
Ars Pharmaceuticals Inc   0.38 $ 116.927  Millions$ 309.380  Millions
Arrowhead Pharmaceuticals Inc   0.37 $ 669.495  Millions$ 1,787.717  Millions
Intelligent Bio Solutions Inc   0.37 $ 4.215  Millions$ 11.273  Millions
Gossamer Bio Inc   0.36 $ 53.286  Millions$ 146.709  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.